Spire Wealth Management’s Insmed INSM Stock Holding History

Spire Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$81.7K	Buy	766 +1	+0.1%	+$121	﹤0.01%	1034
2026 Q1	$125K	Hold	765	–	–	﹤0.01%	920
2025 Q4	$133K	Sell	765 -12	-2%	-$2.19K	﹤0.01%	908
2025 Q3	$112K	Buy	777 +80	+11%	+$9.8K	﹤0.01%	950
2025 Q2	$70.1K	Buy	697 +12	+2%	+$918	﹤0.01%	1096
2025 Q1	$52.3K	Hold	685	–	–	﹤0.01%	1263
2024 Q4	$47.3K	Buy	+685	New	+$49.3K	﹤0.01%	1309
2022 Q1	–	Sell	-993	Closed	-$27K	–	2689
2021 Q4	$27K	Buy	+993	New	+$28.4K	﹤0.01%	2008
2021 Q2	–	Sell	-993	Closed	-$34K	–	2765
2021 Q1	$34K	Buy	+993	New	+$38K	﹤0.01%	1919

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Spire Wealth Management's INSM Position: Q2 2026 in Review

Spire Wealth Management increased its Insmed (INSM) stake by 0.13% in Q2 2026, buying an estimated $121 and bringing the position to 766 shares worth $81.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

Spire Wealth Management first reported a position in INSM in Q1 2021 and has held it in 9 quarters since. The position peaked at $133K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Spire Wealth Management held 766 shares of Insmed worth $81.7K as of Q2 2026.
Spire Wealth Management bought 1 Insmed share in Q2 2026, an estimated $121.
Insmed made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1034 holding.
Spire Wealth Management first reported a position in Insmed in Q1 2021 and has held it in 9 quarters since.
Spire Wealth Management's Insmed position peaked at $133K in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.